The Food and Drug Administration has cleared Boehringer Ingelhein and Lilly’s Jardiance (empagliflozin) 10 mg and 25 mg tablets to lower blood sugar in children 10 years and older with Type 2 diabetes ...
Boehringer Ingelheim and Eli Lilly have received the Food and Drug Administration's green light for Jardiance (empagliflozin) 10 mg tablets to reduce the risk of sustained decline in estimated ...
Yesterday’s FDA approvals of a new indication for empagliflozin and combination empagliflozin with metformin hydrochloride for pediatric type 2 diabetes (T2D) provide a new class of oral drugs to ...
(RTTNews) - The U.S. Food and Drug Administration accepted a supplemental New Drug Application (sNDA) for Jardiance (empagliflozin) investigating a potential new indication to lower blood sugar along ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback